{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:30:54Z","timestamp":1793374254757,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jpsychires.2024.04.008","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T12:31:31Z","timestamp":1712752291000},"page":"66-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Efficacy of Esketamine among patients with treatment resistant depression in a \u2018real world' health-care setting in Israel"],"prefix":"10.1016","volume":"174","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2115-4266","authenticated-orcid":false,"given":"Lior","family":"Dvorak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Bloemhof-Bris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9712-1217","authenticated-orcid":false,"given":"Assaf","family":"Shelef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5108-6930","authenticated-orcid":false,"given":"Dania","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gay","family":"Wexler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ortal","family":"Talmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kfir","family":"Feffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2024.04.008_bib1","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1176\/appi.ajp.2017.16010034","article-title":"A 5-year observational study of patients with treatment-resistant depression treated with vagus nerve stimulation or treatment as usual: comparison of response, remission, and suicidality","volume":"174","author":"Aaronson","year":"2017","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.04.008_bib2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/da.22501","article-title":"Ketamine's mechanism of action: a path to rapid-acting antidepressants","volume":"33","author":"Abdallah","year":"2016","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2024.04.008_bib3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.brs.2014.11.002","article-title":"rTMS of the dorsomedial prefrontal cortex for major depression: safety, tolerability, effectiveness, and outcome predictors for 10 Hz versus intermittent theta-burst stimulation","volume":"8","author":"Bakker","year":"2015","journal-title":"Brain Stimul."},{"key":"10.1016\/j.jpsychires.2024.04.008_bib4","doi-asserted-by":"crossref","first-page":"7138","DOI":"10.1038\/s41598-023-33599-w","article-title":"Modeling the antidepressant treatment response to transcranial magnetic stimulation using an exponential decay function","volume":"13","author":"Berlow","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpsychires.2024.04.008_bib5","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2217\/cer-2022-0149","article-title":"A real-world retrospective study evaluating safety, effectiveness, and cost of intranasal esketamine for treatment-resistant depression_J","volume":"11","author":"Brendle","year":"2022","journal-title":"Comp. Effect. Res."},{"key":"10.1016\/j.jpsychires.2024.04.008_bib6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2147\/NDT.S391096","article-title":"Efficacy and safety of flexibly dosed esketamine nasal spray plus a newly initiated oral antidepressant in adult patients with treatment-resistant depression: a randomized, double-blind, multicenter, active-controlled study conducted in China and USA","volume":"19","author":"Chen","year":"2023","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.jpsychires.2024.04.008_bib7","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jamapsychiatry.2019.1189","article-title":"Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial","volume":"76","author":"Daly","year":"2019","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.04.008_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.brs.2017.10.010","article-title":"Early symptom improvement at 10 sessions as a predictor of rTMS treatment outcome in major depression","volume":"11","author":"Feffer","year":"2018","journal-title":"Brain Stimul."},{"key":"10.1016\/j.jpsychires.2024.04.008_bib9","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/da.22503","article-title":"A study of the pattern of response to rTMS treatment in depression","volume":"33","author":"Fitzgerald","year":"2016","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2024.04.008_bib11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/pcn.12902","article-title":"Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective","volume":"73","author":"Hashimoto","year":"2019","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2024.04.008_bib12","series-title":"Summary of Product Characteristics","article-title":"Spravato\u00ae (esketamine hydrochloride)","year":"2021"},{"issue":"Suppl. E1","key":"10.1016\/j.jpsychires.2024.04.008_bib13","first-page":"14","article-title":"Strategies for switching antidepressants to achieve maximum efficacy","volume":"69","author":"Jefferson","year":"2008","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl. A","key":"10.1016\/j.jpsychires.2024.04.008_bib15","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.clinthera.2005.07.017","article-title":"Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation","volume":"27","author":"Laruelle","year":"2005","journal-title":"Clin. Therapeut."},{"issue":"1","key":"10.1016\/j.jpsychires.2024.04.008_bib16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/acps.13378","article-title":"Real\u2010world evidence of age\u2010independent electroconvulsive therapy efficacy: a retrospective cohort study","volume":"145","author":"Luccarelli","year":"2022","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2024.04.008_bib17","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jad.2022.09.043","article-title":"Real-world experience of Esketamine use to manage treatment-resistant depression: a multicentric study on safety and effectiveness (REAL-ESK study)","volume":"319","author":"Martinotti","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2024.04.008_bib18","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jad.2020.02.023","article-title":"The identification, assessment and management of difficult-to-treat depression: an international consensus statement","volume":"267","author":"McAllister-Williams","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2024.04.008_bib36","doi-asserted-by":"crossref","unstructured":"Nordenskj\u00f6ld, A., von Knorring, L., Engstr\u00f6m, I., 2012. Predictors of the short-term responder rate of electroconvulsive therapy in depressive disorders-a population based study. BMC Psych. 12, 1\u20137.","DOI":"10.1186\/1471-244X-12-115"},{"key":"10.1016\/j.jpsychires.2024.04.008_bib19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/acps.13075","article-title":"Electroconvulsive therapy in bipolar depression \u2013 effectiveness and prognostic factors","volume":"140","author":"Nordenskj\u00f6ld","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2024.04.008_bib20","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1192\/bjo.2023.5","article-title":"Response to electroconvulsive therapy in treatment-resistant depression: nationwide observational follow-up study","volume":"9","author":"Nygren","year":"2023","journal-title":"BJPsych. Open"},{"key":"10.1016\/j.jpsychires.2024.04.008_bib21","first-page":"1","article-title":"Major depressive disorder","volume":"2","author":"Otte","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jpsychires.2024.04.008_bib37","doi-asserted-by":"crossref","unstructured":"Popiolek, K., Bejerot, S., Brus, O., Hammar, \u00c5., Land\u00e9n, M., Lundberg, J., Nordanskog, P., Nordenskj\u00f6ld, A., 2019. Electroconvulsive therapy in bipolar depression\u2013effectiveness and prognostic factors. Acta Psych. Scand., 140 (3), 196\u2013204.","DOI":"10.1111\/acps.13075"},{"key":"10.1016\/j.jpsychires.2024.04.008_bib22","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1176\/appi.ajp.2019.19020172","article-title":"Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a sandomized double-blind active-controlled study","volume":"176","author":"Popova","year":"2019","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.04.008_bib23","first-page":"2019","article-title":"Antidepressant based on party drug gets backing from FDA advisory group","author":"Reardon","year":"2019","journal-title":"Nature News"},{"key":"10.1016\/j.jpsychires.2024.04.008_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.865466","article-title":"Efficacy and safety of intranasal esketamine in patients with treatment-resistant depression and comorbid chronic post-traumatic stress disorder: Open-label single-arm pilot study","volume":"13","author":"Roth\u00e4rmel","year":"2022","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.04.008_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/0004867418808585","article-title":"Difficult-to-treat depression: a clinical and research roadmap for when remission is elusive","volume":"53","author":"Rush","year":"2019","journal-title":"Aust. N. Z. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.04.008_bib26","first-page":"1","article-title":"Esketamine nasal spray in patients with treatment-resistant depression: the real-world experience in the French cohort early-access programme","author":"Samalin","year":"2022","journal-title":"Int. J. Psychiatr. Clin. Pract."},{"key":"10.1016\/j.jpsychires.2024.04.008_bib27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pupt.2014.01.005","article-title":"Randomized Controlled Trials and real life studies. Approaches and methodologies: a clinical point of view","volume":"27","author":"Saturni","year":"2014","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.jpsychires.2024.04.008_bib28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1503\/jpn.180056","article-title":"Unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression: a meta-analysis of randomized controlled trials over 2 decades","volume":"44","author":"Sehatzadeh","year":"2019","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.jpsychires.2024.04.008_bib29","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00787-022-02021-7","article-title":"Transcranial magnetic stimulation in the treatment of adolescent depression: a systematic review and meta-analysis of aggregated and individual-patient data from uncontrolled studies","volume":"31","author":"Sigrist","year":"2022","journal-title":"Eur. Child Adolesc. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.04.008_bib30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jad.2021.05.078","article-title":"Response rate and subjective memory after electroconvulsive therapy in depressive disorders with psychiatric comorbidity","volume":"292","author":"Steinholtz","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2024.04.008_bib31","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41398-021-01488-3","article-title":"Optimizing prediction of response to antidepressant medications using machine learning and integrated genetic, clinical, and demographic data","volume":"11","author":"Taliaz","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"8","key":"10.1016\/j.jpsychires.2024.04.008_bib32","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1080\/03007995.2023.2239045","article-title":"Access and real-world use patterns of esketamine nasal spray among patients with treatment-resistant depression covered by private or public insurance","volume":"39","author":"Teeple","year":"2023","journal-title":"Curr. Med.l Res. Opin."},{"issue":"Suppl. 2","key":"10.1016\/j.jpsychires.2024.04.008_bib33","first-page":"3","article-title":"Effectiveness of antidepressants: Comparative remission rates","volume":"64","author":"Thase","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2024.04.008_bib34","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1213\/ANE.0000000000002594","article-title":"General anesthetics to treat major depressive disorder: clinical relevance and underlying mechanisms","volume":"126","author":"Vutskits","year":"2018","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.jpsychires.2024.04.008_bib35","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.22m14706","article-title":"50% Improvement: Should treatment response go beyond symptom improvement when evaluating the treatment of depression?","volume":"84","author":"Zimmerman","year":"2023","journal-title":"J. Clin. Psychiatry"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395624002036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395624002036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:43:49Z","timestamp":1715820229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395624002036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":35,"alternative-id":["S0022395624002036"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2024.04.008","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Esketamine among patients with treatment resistant depression in a \u2018real world' health-care setting in Israel","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2024.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}